STOCK TITAN

Nukkleus Inc. Warrants (NUKKW) Financials

NUKKW
FY2025 annual
Net Income $78.5M +1022.0% YoY
EPS (Diluted) $7.96 YoY not available
Free Cash Flow -$6.2M YoY not available
Operating Cash Flow -$6.2M -62.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-K for Q1 FY2026, filed Jun 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NUKKW SEC filings page.

This page shows Nukkleus Inc. Warrants (NUKKW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NUKKW FY2025

Reported profit in FY2025 came alongside operating losses, negative cash generation, and a balance sheet funded more by liabilities than equity.

The gap between net income of $78.5M and an operating loss of $32.6M shows that the reported profit did not come from the core operating result. Operating cash flow of -$6.2M confirms that accounting earnings did not translate into cash generation.

Assets rose from $1.0M in FY2024 to $202.4M in FY2025. Liabilities reached $222.2M against negative equity, so the expansion was not supported by a positive capital cushion.

The current ratio improved from 0.1x in FY2024 to 0.3x in FY2025 but remained below parity, leaving short-term obligations larger than current assets. Financing inflows of $182.0M nearly offset investing outflows of $179.8M, making external financing and investment activity more important to cash movement than operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Nukkleus Inc. Warrants does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/6

Nukkleus Inc. Warrants passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Nukkleus Inc. Warrants used $0.08 of operating cash (-$6.2M OCF vs $78.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage At Risk
N/A

Nukkleus Inc. Warrants reported an operating loss of $32.6M against $154K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.7M

Nukkleus Inc. Warrants generated $3.7M in revenue in Q1 2026.

EBITDA
-$3.8M
YoY-176.3%

Nukkleus Inc. Warrants's EBITDA was -$3.8M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 176.3% from the same quarter a year earlier.

Net Income
-$27.1M

Nukkleus Inc. Warrants reported -$27.1M in net income in Q1 2026.

EPS (Diluted)
-$1.14

Nukkleus Inc. Warrants earned -$1.14 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Free Cash Flow
-$5.1M
YoY-275.8%
QoQ-402.6%

Nukkleus Inc. Warrants recorded an outflow of $5.1M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 275.8% from the same quarter a year earlier. Against the prior quarter it is down 402.6%.

Cash & Debt
$6.4M
YoY+44.1%
QoQ+144.8%
5Y CAGR+59.3%

Nukkleus Inc. Warrants held $6.4M in cash against $3.1M in long-term debt as of Q1 2026, with $91.6M of liabilities due within a year.

Shares Outstanding
38M
5Y CAGR+90.4%

Nukkleus Inc. Warrants had 38M shares outstanding in Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
10.2%

Nukkleus Inc. Warrants's gross margin was 10.2% in Q1 2026, indicating the percentage of revenue retained after direct costs.

Return on Equity
-75.1%

Nukkleus Inc. Warrants's ROE was -75.1% in Q1 2026, measuring profit generated per dollar of shareholder equity.

Operating Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$274K

Nukkleus Inc. Warrants invested $274K in research and development in Q1 2026.

Capital Expenditures
$154K
YoY+1440.0%
QoQ+1151.0%

Nukkleus Inc. Warrants invested $154K in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 1440.0% from the same quarter a year earlier. Against the prior quarter it is up 1151.0%.

Share Buybacks

Not reported for Q1 2026.

NUKKW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUKKW quarterly income statement
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-KQ3'2410-QQ2'24
Revenue$3.7MN/AN/AN/AN/AN/A$236K-95.3%$175K-96.6%
Cost of Revenue$3.3MN/AN/AN/AN/AN/A$18K-99.7%$50K-99.1%
Gross Profit$371KN/AN/AN/AN/AN/A$218K+178.3%$125K+179.4%
R&D Expenses$274KN/AN/AN/AN/AN/AN/AN/A
SG&A Expenses$3.5M+134.1%N/A$231K+333.1%$71K+186.0%$1.5M+4923.3%$4.5M$53K$25K
Operating Income-$3.8M-152.9%N/A-$4.8M-301.4%-$1.0M-1.8%-$1.5M+27.7%-$4.5M-61.5%-$1.2M-918.9%-$1.0M+15.1%
EBITDA-$3.8M-176.3%N/AN/AN/A-$1.4MN/AN/AN/A
Interest Expense$354K+115.1%N/A$36K-88.0%$20K-50.4%$165K+1490.4%$439K+5814.8%$304K$40K
Income Tax$38KN/AN/AN/AN/AN/AN/AN/A
Net Income-$27.1MN/A-$16.4M-467.3%$3.0M+286.8%N/AN/A$4.5M+3634.2%-$1.6M-33.6%
EPS (Basic)-$1.01-104.9%N/A-$2.02-192.7%$0.58+164.4%$20.76+1604.3%-$51.96-668.6%$2.18+3214.3%-$0.90-650.0%
EPS (Diluted)-$1.14N/A-$2.02$0.54$18.15-$51.96$2.18+3214.3%-$0.90
Diluted Shares (Avg)31MN/A8M6M6M3M2M+6.8%2M

NUKKW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUKKW quarterly balance sheet
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-KQ3'2410-QQ2'24
Total Assets$315.5M+3567.7%$202.4M+2121.8%$13.3M+1249.0%$7.1M+538.1%$8.6M+601.8%$9.1M+282.5%$985K-70.6%$1.1M-75.6%
Current Assets$22.8M+169.5%$13.6M+49.1%$13.1M+1258.4%$7.0M+885.2%$8.5M+947.1%$9.1M+364.0%$966K-67.0%$706K-84.6%
Cash & Equivalents$6.4M+44.1%$2.6M-61.9%$7.6M+2040507.2%$1.5M+24658.0%$4.5M+1360.4%$6.9M+3278.9%$373-95.2%$6K-95.7%
Inventory$3.5MN/AN/AN/AN/AN/AN/AN/A
Accounts Receivable$3.6M$506KN/AN/AN/AN/AN/AN/A
Goodwill$100.2M$7.7MN/AN/AN/AN/AN/AN/A
Total Liabilities$279.3M+324.4%$222.2M+28.8%$43.7M+440.7%$60.5M+353.4%$65.8M+416.2%$172.5M+1298.9%$8.1M-15.3%$13.4M+493.9%
Current Liabilities$91.6M+41.6%$43.5M-74.6%$43.6M+517.1%$60.4M+398.3%$64.7M+448.8%$171.4M+1375.1%$7.1M-22.5%$12.1M+169.3%
Non-Current Liabilities$6.8M+510.1%$1.6M+62.5%$75K-92.6%$107K-91.2%$1.1M+15.8%$1.0M+43.1%$1.0M+139.7%$1.2M+115.5%
Long-Term Debt$3.1M+96.8%N/A$1.6M-52.7%$1.6M$1.6M$1.6M$3.3MN/A
Total Equity$36.2M+163.2%-$19.8M+87.9%-$30.4M-328.6%-$53.4M-336.5%-$57.2M-396.5%-$163.3M-1542.3%-$7.1M-14.6%-$12.2M-253.1%
Retained Earnings-$149.7M-52.5%-$122.5M+39.1%-$111.5M-176.7%-$95.1M-94.1%-$98.1M-107.1%-$201.1M-347.4%-$40.3M-26.8%-$49.0M-488.3%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

NUKKW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUKKW quarterly cash flow statement
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-KQ3'2410-QQ2'24
Operating Cash Flow-$4.9M-267.1%-$999K-193.7%-$2.5M-109.0%-$1.4M-82.6%-$1.3M-19.5%-$340K+53.9%-$1.2M-97.9%-$741K-159.0%
Depreciation & Amortization$22K-83.8%N/AN/AN/A$136KN/AN/AN/A
Stock-Based Compensation$1.9M+971.3%N/AN/AN/A$178K+138.4%$6K-99.7%N/AN/A
Capital Expenditures$154K+1440.0%$12K$4K$5K$10KN/AN/AN/A
Free Cash Flow-$5.1M-275.8%-$1.0M-$2.5M-$1.4M-$1.4MN/AN/AN/A
Investing Cash Flow-$3.8M-372.0%-$176.3M-18736.4%-$2.0M-159135.2%-$705K-284312.5%-$810K-59878.6%-$936K-819.2%$1K+100.1%$248+153.8%
Financing Cash Flow$12.5M$173.6M+1815.9%$9.2M+1211.9%N/AN/A$9.1M+1114.6%$703K+432.6%$631K+201.0%
Dividends Paid$297KN/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Share Buybacks.

NUKKW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUKKW quarterly financial ratios
MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-KQ3'2410-QQ2'24
Gross Margin10.2%N/AN/AN/AN/AN/A92.2%+97.7pp71.6%+74.6pp
Operating Margin-104.3%N/AN/AN/AN/AN/A-503.5%-587.5%
Net Margin-743.1%N/AN/AN/AN/AN/A1887.0%-922.4%
Return on Equity-75.1%N/AN/AN/AN/AN/AN/AN/A
Return on Assets-8.6%N/A-123.2%-575.5pp42.2%+186.5ppN/AN/A452.3%+456.1pp-144.3%-118.0pp
Current Ratio0.25+0.1x0.31+0.3x0.30+0.2x0.12+0.1x0.13+0.1x0.05-0.1x0.14-0.2x0.06-1.0x
Debt-to-Equity0.09N/AN/AN/AN/AN/AN/AN/A
Asset Turnover0.01N/AN/AN/AN/AN/A0.24-1.3x0.16-1.0x
FCF Margin-139.1%N/AN/AN/AN/AN/AN/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$19.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.31), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Nukkleus Inc. Warrants NUKKW FY2025 N/A $78.5M N/A N/A —
Vimeo, Inc. VMEO FY2024 $417.0M $27.0M 6.5% $1.3B 41/100
MeridianLink, Inc. MLNK FY2024 $316.3M -$29.8M -9.4% $1.5B 51/100
Jamf Holding Corp. JAMF FY2024 $627.4M -$68.5M -10.9% $1.7B 42/100
Donnelley Financial Solutions, Inc. DFIN FY2025 $767.0M $32.4M 4.2% $1.2B 57/100
Upbound Group, Inc. UPBD FY2025 $4.7B $73.0M 1.6% $897.8M 29/100

Frequently Asked Questions

Is Nukkleus Inc. Warrants profitable?

Yes, Nukkleus Inc. Warrants (NUKKW) reported a net income of $78.5M in fiscal year 2025.

What is Nukkleus Inc. Warrants's earnings per share (EPS)?

Nukkleus Inc. Warrants (NUKKW) reported diluted earnings per share of $7.96 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Nukkleus Inc. Warrants's EBITDA?

Nukkleus Inc. Warrants (NUKKW) had EBITDA of -$32.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Nukkleus Inc. Warrants (NUKKW) recorded an outflow of $6.2M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Nukkleus Inc. Warrants (NUKKW) recorded an outflow of $6.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Nukkleus Inc. Warrants (NUKKW) had $202.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Nukkleus Inc. Warrants (NUKKW) invested $31K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Nukkleus Inc. Warrants (NUKKW) had 19M shares outstanding as of fiscal year 2025.

Nukkleus Inc. Warrants (NUKKW) had a current ratio of 0.31 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Nukkleus Inc. Warrants (NUKKW) had a return on assets of 38.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Nukkleus Inc. Warrants (NUKKW) has negative shareholder equity of -$19.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Nukkleus Inc. Warrants (NUKKW) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Nukkleus Inc. Warrants (NUKKW) used $0.08 of operating cash (-$6.2M OCF vs $78.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Nukkleus Inc. Warrants (NUKKW) reported an operating loss of $32.6M against $154K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top